
Core Laboratories
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $121,797 | $138,255 | $134,521 | $130,159 |
Gross Profit | 19,724 | 25,071 | 26,026 | 22,788 |
EBITDA | 5,651 | 19,500 | 24,522 | 22,678 |
EBIT | 1,887 | 15,832 | 20,928 | 15,291 |
Net Income | -789 | 4,948 | 14,239 | 10,636 |
Net Change In Cash | 121,797 | 138,255 | 134,521 | 130,159 |
Free Cash Flow | -926 | 4,311 | 5,470 | 10,084 |
Cash | 22,819 | 22,702 | 25,629 | 31,188 |
Basic Shares | 46,073 | 46,500 | 47,078 | 47,509 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $526,520 | $523,848 | $509,790 | $489,735 |
Gross Profit | 94,284 | 88,373 | 94,049 | 78,919 |
EBITDA | 71,117 | 73,509 | 70,424 | 58,685 |
EBIT | 56,468 | 58,556 | 54,640 | 41,524 |
Net Income | 29,669 | 31,400 | 36,675 | 19,453 |
Net Change In Cash | 526,520 | 523,848 | 509,790 | 489,735 |
Cost of Revenue | -2,275 | |||
Free Cash Flow | 22,587 | 43,360 | 14,210 | 14,740 |
Cash | 22,702 | 19,157 | 15,120 | 15,428 |
Basic Shares | 46,500 | 47,685 | 47,523 | 46,813 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.06 |
2025-12-31 | $0.21 |
2025-09-30 | $0.22 |
2025-06-30 | $0.19 |